ImmunoQure AG

Rare, natural autoantibodies derived from patients, for patients

ImmunoQure AG is a young biotech company spearheading the research & development of human-derived autoantibodies for the treatment of human diseases. Through our unique access to rare patient populations, we are able to correlate clinical status with serological profiles and subsequently clone autoantibodies which the patient’s own immune system has optimized against key drug targets involved in preventing a number of human diseases.